KOSDAQ - Delayed Quote KRW

Daesung Microbiological Labs. Co., Ltd. (036480.KQ)

10,570.00 +30.00 (+0.28%)
At close: 3:30 PM GMT+9
Loading Chart for 036480.KQ
DELL
  • Previous Close 10,540.00
  • Open 10,620.00
  • Bid --
  • Ask --
  • Day's Range 10,530.00 - 10,620.00
  • 52 Week Range 9,690.00 - 19,450.00
  • Volume 8,890
  • Avg. Volume 46,753
  • Market Cap (intraday) 40.166B
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

www.dsmbio.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: 036480.KQ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

036480.KQ
3.47%
KOSPI Composite Index
0.04%

1-Year Return

036480.KQ
8.04%
KOSPI Composite Index
6.90%

3-Year Return

036480.KQ
46.80%
KOSPI Composite Index
17.44%

5-Year Return

036480.KQ
51.05%
KOSPI Composite Index
21.89%

Compare To: 036480.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 036480.KQ

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.66%

  • Return on Assets (ttm)

    -0.67%

  • Return on Equity (ttm)

    -1.78%

  • Revenue (ttm)

    25.56B

  • Net Income Avi to Common (ttm)

    -679.68M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.73B

  • Total Debt/Equity (mrq)

    64.29%

  • Levered Free Cash Flow (ttm)

    -1.86B

Company Insights: 036480.KQ

People Also Watch